Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eprosartan Mesylate (SKF-108566J) is a competitive and reversible Angiotensin II Receptor Blocker.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 40.00 | |
25 mg | In stock | $ 63.00 | |
50 mg | In stock | $ 77.00 | |
100 mg | In stock | $ 112.00 | |
200 mg | In stock | $ 173.00 | |
500 mg | In stock | $ 292.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 40.00 |
Description | Eprosartan Mesylate (SKF-108566J) is a competitive and reversible Angiotensin II Receptor Blocker. |
Targets&IC50 | AT1 receptor:0.83 nM(Kd) |
In vitro | In a study involving brain and spinal cord injured rats, Eprosartan (0.3 mg/kg i.v.) was observed to induce a hypertensive response following spinal cord stimulation. |
In vivo | Eprosartan effectively inhibits [125I]-Angiotensin II in human tissues (adrenal cortex, liver, cloned AT1 receptors) with an IC50 range of 1.4-3.9 nM and in rat tissues (mesenteric artery, adrenal cortex, glomeruli) with an IC50 range of 1.5-9.2 nM. In isolated perfused proximal tubules of rabbits, Eprosartan (100 nM) completely blocks the isosmotic fluid absorption induced by Angiotensin II. |
Synonyms | SKF-108566J |
Molecular Weight | 520.62 |
Formula | C23H24N2O4S·CH4O3S |
CAS No. | 144143-96-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 4 mg/mL (7.68 mM)
DMSO: 104 mg/mL (199.76 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eprosartan Mesylate 144143-96-4 Endocrinology/Hormones RAAS inhibit angiotensin-II nonpeptid SKF-108566J antihypertensive Angiotensin Receptor Eprosartan AT1 Inhibitor inhibitor